By Leigh Parry
British scientists have developed a new treatment that transports ‘tumour busting’ genes selectively to cancer cells, it was announced today.
The breakthrough could help people with cancers that are inoperable because they are close to vital organs, like the brain or lungs, according to a report in the journal Cancer Research.
Using nanotechnology, researchers packaged anti-cancer genes in very small particles that directed the treatment selectively to tumours in mice. Healthy cells were unharmed.
Study author, Cancer Research UK’s Dr Andreas Schatzlein from the School of Pharmacy in London said it was the first time that nanoparticles were shown to target tumours in such a selective way.
“Once inside the cell, the gene enclosed in the particle recognizes the cancerous environment and switches on. The result is toxic, but only to the offending cells, leaving healthy tissue unaffected.
“We hope this therapy will be used to treat cancer patients in clinical trials in a couple of years.”
Cancer Research UK’s director of cancer information Dr Lesley Walker said the results were encouraging.
“Gene therapy is an exciting area of research, but targeting genetic changes to cancer cells has been a major challenge.”
Cancer Res first published on March 3, 2009 as doi:10.1158/0008-5472.CAN-08-2657

Leave a Reply